UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A call for concern: Frailty in middle‐aged adults with alcohol use disorder

Drug and alcohol review, 2024-01, Vol.43 (1), p.347-349

2024

Volltextzugriff (PDF)

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol

BMC psychiatry, 2024-03, Vol.24 (1), p.175-175, Article 175

2024

Volltextzugriff (PDF)

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

Substance abuse treatment, prevention and policy, 2022-10, Vol.17 (1), p.67-12, Article 67

2022

Volltextzugriff (PDF)

Exercise increases plasma THC concentrations in regular cannabis users

Drug and alcohol dependence, 2013-12, Vol.133 (2), p.763-767

2013

Volltextzugriff (PDF)

Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics

Current topics in behavioral neurosciences, 2017, Vol.34, p.125-139

2017

Volltextzugriff (PDF)

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol

BMC psychiatry, 2018-05, Vol.18 (1), p.140-14, Article 140

2018

Volltextzugriff (PDF)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients

Journal of cannabis research, 2021-07, Vol.3 (1), p.33-33, Article 33

2021

Volltextzugriff (PDF)

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal

Drug and alcohol review, 2008-05, Vol.27 (3), p.326-333

2008

Volltextzugriff (PDF)

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial

Health science reports, 2020-06, Vol.3 (2), p.e151-n/a

2020

Volltextzugriff (PDF)

A survey of Australian psychiatrists’ and psychiatry trainees’ knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders

Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists, 2023-06, Vol.31 (3), p.329-335

2023

Volltextzugriff (PDF)

The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls

Addiction (Abingdon, England), 2022-06, Vol.117 (6), p.1589-1597

2022

Volltextzugriff (PDF)

The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) – a case report

Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists, 2021-12, Vol.29 (6), p.707-707

2021

Volltextzugriff (PDF)

Identifying and responding to fetal alcohol spectrum disorder in child and family health: Lessons from an exploratory mixed methods study

Drug and alcohol review, 2024-09, Vol.43 (6), p.1505-1514

2024

Volltextzugriff (PDF)

Tobacco dependence management in a smoke-free inpatient drug and alcohol unit

Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists, 2021-02, Vol.29 (1), p.14-21

2021

Volltextzugriff (PDF)

Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial

Drug and alcohol dependence, 2020-10, Vol.215, p.108220, Article 108220

2020

Volltextzugriff (PDF)

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial

JAMA psychiatry (Chicago, Ill.), 2014-03, Vol.71 (3), p.281

2014

Volltextzugriff (PDF)

Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand

Australian and New Zealand journal of psychiatry, 2024-10, Vol.58 (10), p.831-838

2024

Volltextzugriff (PDF)

Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial

JAMA internal medicine, 2019-09, Vol.179 (9), p.1242

2019

Volltextzugriff (PDF)

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial

The American journal of psychiatry, 2024-05, Vol.181 (5), p.403-411

2024

Volltextzugriff (PDF)

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

The International journal of drug policy, 2022-02, Vol.100, p.103492-103492, Article 103492

2022

Volltextzugriff (PDF)

Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

Drug and alcohol dependence, 2022-05, Vol.234, p.109388-109388, Article 109388

2022

Volltextzugriff (PDF)

Substance use, socio‐demographic characteristics, and self‐rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study

Medical journal of Australia, 2023-09, Vol.219 (5), p.218-226

2023

Volltextzugriff (PDF)

Oral health status and oral health-related quality of life: a cross-sectional study of clients in an Australian opioid treatment program

Australian journal of primary health, 2024-08, Vol.30 (5)

2024

Volltextzugriff (PDF)

Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids

Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists, 2019-02, Vol.27 (1), p.80-85

2019

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A call for concern: Frailty in middle‐aged adults with alcohol use disorder

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study

Exercise increases plasma THC concentrations in regular cannabis users

Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial

A survey of Australian psychiatrists’ and psychiatry trainees’ knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders

The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls

The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) – a case report

Identifying and responding to fetal alcohol spectrum disorder in child and family health: Lessons from an exploratory mixed methods study

Tobacco dependence management in a smoke-free inpatient drug and alcohol unit

Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial

Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand

Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

Substance use, socio‐demographic characteristics, and self‐rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study

Oral health status and oral health-related quality of life: a cross-sectional study of clients in an Australian opioid treatment program

Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids

Suchergebnisse filtern